Patents-Review.com
🔗 Permalink
Assignee profile:

Ethris GmbH

City:

Planegg

Country:

Germany

Published Applications:

20

Last publication date:

2025-10-16

Patent Grants:

19

Last grant date:

2026-04-07

Top Inventors for applications by Ethris GmbH

These are the the leading inventors for applications assigned to Ethris GmbH:

Recent patent applications by Ethris GmbH

Ethris GmbH based in Planegg, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-10-16
US20250319160A1
Human necessities

USE OF IFN-LAMBDA MRNA FOR TREATING VIRAL INFECTIONS

 #2 | 2023-09-28 ✅ Patent 12,594,295 granted on 2026-04-07
US20230302039A1
Human necessities

CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES

 #3 | 2023-03-23 ✅ Patent 11,981,910 granted on 2024-05-14
US20230086606A1
Chemistry; metallurgy

Minimal UTR sequences

 #4 | 2021-05-13 ✅ Patent 12,465,568 granted on 2025-11-11
US20210137846A1
Human necessities

CRYOPROTECTIVE AGENTS FOR PARTICULATE FORMULATIONS

 #5 | 2021-01-14 ✅ Patent 12,522,821 granted on 2026-01-13
US20210009995A1
Chemistry; metallurgy

POLYRIBONUCLEOTIDE CONTAINING DEUTERATED NUCLEOTIDES

 #6 | 2020-10-01 ✅ Patent 11,104,887 granted on 2021-08-31
US20200308556A1
Chemistry; metallurgy

Ornithine transcarbamylase coding polyribonucleotides and formulations thereof

 #7 | 2020-02-13 ✅ Patent 11,510,937 granted on 2022-11-29
US20200046752A1
Human necessities

CFTR MRNA compositions and related methods and uses

 #8 | 2019-12-19 ✅ Patent 11,065,346 granted on 2021-07-20
US20190381193A1
Human necessities

RNA for use in the treatment of ligament or tendon lesions

 #9 | 2019-06-27 ✅ Patent 11,136,585 granted on 2021-10-05
US20190194669A1
Chemistry; metallurgy

UTRs increasing the translation efficiency of RNA molecules

 #10 | 2019-05-16 ✅ Patent 11,352,638 granted on 2022-06-07
US20190144883A1
Chemistry; metallurgy

Minimal UTR sequences

 #11 | 2019-03-28 ✅ Patent 10,583,195 granted on 2020-03-10
US20190091342A1
Human necessities

Conjugate with target-finding ligand and use thereof

 #12 | 2018-12-27 ✅ Patent 11,479,768 granted on 2022-10-25
US20180371456A1
Chemistry; metallurgy

ATP-binding cassette family coding polyribonucleotides and formulations thereof

 #13 | 2018-08-23 ✅ Patent 11,020,487 granted on 2021-06-01
US20180236090A1
Human necessities

Compositions for introducing nucelic acid into cells

 #14 | 2018-08-02 ✅ Patent 12,263,229 granted on 2025-04-01
US20180214572A1
Human necessities

Induction of osteogenesis by delivering BMP encoding RNA

 #15 | 2018-06-14 ✅ Patent 10,927,383 granted on 2021-02-23
US20180163213A1
Chemistry; metallurgy

Cas9 mRNAs

 #16 | 2017-09-07 ✅ Patent 10,080,804 granted on 2018-09-25
US20170252455A1
Human necessities

Conjugate with target-finding ligand and use thereof

 #17 | 2017-07-06 ✅ Patent 10,272,161 granted on 2019-04-30
US20170189552A1
Human necessities

RNA for use in the treatment of ligament or tendon lesions

 #18 | 2017-01-26 ✅ Patent 12,064,484 granted on 2024-08-20
US20170021036A1
Human necessities

Compositions for introducing RNA into cells

 #19 | 2016-06-23 ✅ Patent 10,745,698 granted on 2020-08-18
US20160177295A1
Chemistry; metallurgy

RNA with a combination of unmodified and modified nucleotides for protein expression

 #20 | 2014-11-20 ✅ Patent 9,555,122 granted on 2017-01-31
US20140341995A1
Human necessities

Conjugate with target-finding ligand and use thereof

Also check out ethris GmbH's (Planegg, Germany) applicant profile with 23 patent applications submitted.

AssigneeID:

137820 ⎘